MI:RNA (UK)

Identification of early-stage heart disease using serum biomarkers and AI modelling. Available now for disease detection and screening of predisposed patients:

• Sensitivity – 84%
• Specificity – 76%
• Results include heart disease categorisation
• Enables risk stratification, screening and monitoring of cases, even in pre-symptomatic patients
• Standalone test for diagnosis
• AI modelling enables clear interpretation

Submiting samples is easy with our bespoke web-app. Submit a sample to auto generate a packing slip, track progress and get real time results from within the app.